Abstract
The present paper reviews the role of antianxiety agents in the treatment of nonpsychotic anxious patients. Major emphasis is placed on findings from clinical trials conducted by this research group. Consideration is given to the relative efficacy of available antianxiety agents, to patient response in relation to patterns of symptomatology, and to the degree of symptom relief experienced by drug-treated anxious patients. Also discussed are some of the many nonspecific factors that affect improvement with drug treatment in general and with the benzodiazepines in particular. It is concluded that many anxious patients are not currently receiving adequate drug treatment, and may require longer periods of drug therapy or supplemental nondrug intervention.
Similar content being viewed by others
References
Benson, W. H.: Comparative evaluation of diazepam (Valium) and phenobarbital for the relief of anxiety-related symptoms in patients hospitalized for acute myocardial infarction. J. Med. Assoc. Ga. 60, 276–278 (1971)
Berger, F. M.: The similarities and differences between meprobamate and barbiturates. Clin. Pharmacol. Ther. 4, 209–231 (1963)
Berger, F. M.: The role of drugs in suicide. In: Symposium on suicide, L. Yochelson, ed. Washington, D. C.: George Washington University 1967
Blackwell, B.: Psychotropic drugs in use today: the role of diazepam in medical practice. JAMA 225, 1637–1641 (1973)
Byck, R.: Drugs and the treatment of psychiatric disorders. In: The pharmacological basis of therapeutics, 5th ed., L. S. Goodman and A. Gilman, eds., p. 188. New York: Macmillan 1975
Cohen, J., Gomez, E., Hoell, N. L., Kotin, J., Rickman, E. E., Roessler, R. L.: Diazepam and phenobarbital in the treatment of anxiety: a controlled multicenter study using physician and patient rating scales. Curr. Ther. Res. 20, 184–193 (1976)
Cooper, A. J., Magnus, R. V., Rose, M., Phanjoo, A., Lancaster, N. P., Pollard, P., Knowlson, P.: Controlled trial of dipotassium chlorazepate (‘Tranxene’) in anxiety. Br. J. Psychiatry 123, 475–476 (1973)
Covi, L., Lipman, R. S., Pattison, J. H., Derogatis, L. R., Uhlenhuth, E. H.: Length of treatment with anxiolytic sedatives and response to their sudden withdrawal. Acta Psychiatr. Scand. 49, 51–64 (1973)
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., Covi, L.: The Hopkins symptom checklist (HSCL): a measure of primary symptom dimensions. In: Psychological measurements in psychopharmacology, vol. 7, P. Pichot, ed., pp. 79–110. Basel: Karger 1974
DeSilverio, R. V., Rickels, K., Raab, E., Jameson, J. J.: Oxazepam and meprobamate in anxious neurotic outpatients. J. Clin. Pharmacol. 9, 259–263 (1969)
DiMascio, A., Shader, R. I., Harmatz, J.: Psychotropic drugs and induced hostility. Psychosomatics 10, 46–47 (1969)
Dunbar, R. W., Boettner, R. B., Haley, J. V., Hall, V. E., Morrow, D. H.: The effect of diazepam on the antiarrhytmic response to lidocaine. Anesth. Analg. 50, 685–692 (1971)
Dureman, I., Norrman, B.: Clinical and experimental comparison of diazepam, chlorazepate and placebo. Psychopharmacologia (Berl.) 40, 279–284 (1975)
Goldberg, H. L., Finnerty, R. J.: A double-blind study of prazepam vs. placebo in single doses in the treatment of anxiety. Comp. Psychiatry 18, 147–156 (1977)
Greenblatt, D. J., Shader, R. I.: Benzodiazepines in clinical practice. New York: Raven 1974
Greenblatt, D. J., Shader, R. I., Koch-Weser, J.: Flurazepam hydrochloride. Clin. Pharmacol. Ther. 17, 1–14 (1975)
Hackett, T. P., Cassem, N. H.: Reduction of anxiety in the coronarycare unit: a controlled double-blind comparison of chlordiazepoxide and amobarbital. Curr. Ther. Res. 14, 649–656 (1972)
Hamilton, M.: The assessment of anxiety states by rating. Br. J. Med. Psychol. 32, 50–55 (1959)
Hesbacher, P. T., Rickels, K., Hutchison, J., Raab, E., Sablosky, L., Whalen, E. M., Phillips, F. J.: Setting, patient, and doctor effects on drug response in neurotic patients. II. Differential improvement. Psychopharmacologia (Berl.) 18, 209–226 (1970)
Hesbacher, P. T., Rickels, K., Downing, R. W., Stepansky, P.: Assessment of psychiatric illness severity by family physicians. Soc. Sci. Med. 12, 45–47 (1978)
Hesbacher, P. T., Rickels, K., Gordon, P. E., Gray, B., Meckelnburg, R., Weise, C. C., Vandervort, W. J.: Setting, patient, and doctor effects on drug response in neurotic patients. I. Differential attrition, dosage deviation, and side reaction response to treatment. Psychopharmacologia (Berl.) 18, 180–208 (1970)
Hesbacher, P. T., Rickels, K., Rial, W. Y., Segal, A., Zamostein, B. B.: Psychotropic drug prescription in family practice. Comp. Psychiatry 17, 607–615 (1976)
Hollister, L. E.: Overdoses of psychotherapeutic drugs. Clin. Pharmacol. Ther. 7, 142–146 (1966)
Hollister L. E., Glazener, F. S.: Withdrawal reactions from meprobamate, alone and combined with promazine: a controlled study. Psychopharmacologia (Berl.) 1, 336–341 (1960)
Hollister, L. E., Motzenbecker, F. P., Degan, R. O.: Withdrawal reactions from chlordiazepoxide (“Librium”). Psychopharmacologia (Berl.) 2, 63–68 (1961)
Hollister, L. E., Overall, J. E., Pokorny, A. D., Shelton, J.: Acetophenazine and diazepam in anxious depressions. Arch. Gen. Psychiatry 24, 273–278 (1971)
Hollister, L. E., Overall, J. E., Shelton, J., Pennington, V., Kimbell, I., Johnson, M.: Drug therapy of depression. Arch. Gen. Psychiatry 17, 486–493 (1967)
Jenner, F. A., Parkin, D.: A large overdose of chlordiazepoxide. Lancet 1961 II, 322–323
Joyce, C. R. B.: Can drugs affect personality? In: Ciba Foundation on Personality and Science, I. T. Ramsey and R. Porter, eds., pp. 65–72. London: Churchill Livingstone 1971
Klein, D. F.: Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia (Berl.) 5, 397–408 (1964)
Klerman, G. L.: Psychotropic drugs as therapeutic agents. Hastings Center Studies, vol. 2, No. 1, pp. 81–93 (1974)
Klerman, G. L., DiMascio, A., Weissman, M., Prusoff, B., Paykel, E. S.: Treatment of depression by drugs and psychotherapy. Am. J. Psychiatry 131, 186–191 (1974)
Lader, M. H.: The peripheral and central role of the catecholamin in the mechanisms of anxiety. Int. Pharmacopsychiatry 9, 125–137 (1974)
Lader, M. H., Bond, A. J., James, D. C.: Clinical comparison of anxiolytic drug therapy. Psychol. Med. 4, 381–387 (1974)
Lipman, R. S., Covi, L., Rickels, K., Uhlenhuth, E. H., Lazar, R.: Selected measures of change in outpatient drug evaluation. In: Psychopharmacology: a review of progress, 1957–1967, D. H. Efron, J. O. Cole, J. Levine and J. R. Wittenborn, eds., pp. 249–254. Public Health Service Publication No. 1836 (1968)
Lipman, R. S., Uhlenhuth, E. H., Rickels, K., Covi, L.: Medication attitudes and drug response. Dis. Nerv. Syst. 30, 454–459 (1969)
Luborsky, L., Auerbach, A. H., Chandler, M., Cohen, J.: Factors influencing the outcome of psychotherapy: a review of quantitative research. Psychol. Bull. 75, 145–185 (1971)
McMillin, W. P.: Oxprenolol in anxiety. Lancet 1973 I, 1193
Merlis, S., Koepke, H. H.: The use of oxazepam in elderly patients. Dis. Nerv. Syst. 36, 27–29 (1975)
Overall, J. E., Hollister, L. E., Meyer, F., Kimbell, I., Shelton, J.: Imipramine and thioridazine in depressed and schizophrenic patients. JAMA 189, 605–608 (1964)
Parry, H. J., Balter, M. B., Mellinger, G. D., Cisin, I. H., Manheimer, D. I.: National patterns of psychotherapeutic drug use. Arch. Gen. Psychiatry 28, 769–783 (1973)
Ramsey, I., Greer, S., Bagley, C.: Propranolol in neurotic and thyrotoxic anxiety. Br. J. Psychiatry 122, 555–560 (1973)
Rickels, K.: Antineurotic agents: specific and non-specific effects. In: Psychopharmacology: a review of progress, 1957–1967, D. H. Efron, J. O. Cole, J. Levine, J. R. Wittenborn, eds., pp. 231–247. Public Health Service Publication No. 1836 (1968)
Rickels, K., ed.: Non-specific factors in drug therapy. Springfield, Ill.: Charles C. Thomas 1968
Rickels, K.: Predictors of response to benzodiazepines in anxious outpatients. In: The benzodiazepines, S. Garattini, E. Mussini and O. Randall, eds., pp. 391–404. New York: Raven 1973
Rickels, K., Case, W. G., Csanolosi, I., Pereira-Ogan, J., Sandler, K. R., Schless, A. P.: Loxapine in neurotic anxiety: a controlled trial. Curr. Ther. Res. 23, 111–120 (1978)
Rickels, K., Chung, H. R., Feldman, H. S., Gordon, P. E., Kelly, E. A., Weise, C. C.: Amitriptyline, diazepam, and phenobarbitol sodium in depressed outpatients. J. Nerv. Ment. Dis. 157, 442–451 (1973)
Rickels, K., Clark, T. W., Ewing, J. H., Klingensmith, W. C., Morris, H.: Evaluation of tranquilizing drugs in medical outpatients. JAMA 171, 1649–1656 (1959)
Rickels, K., Downing, R. W.: Minor tranquilizers in anxiety: some prognostic indicators. In: Relaxation therapy for psychosomatic disorders, P. Kielholz, ed., pp. 11–34. Basel: Ciba-Geigy Ltd., 1971
Rickels, K., Downing, R. W.: Chlordiazepoxide and hostility in anxious outpatients. Am. J. Psychiatry 131, 442–444 (1974)
Rickels, K., Garcia, C.-R., Fisher, E.: A measure of emotional distress in private gynecologic practice. Obstet. Gynecol. 38, 139–146 (1971)
Rickels, K., Gingrich, R. L., Morris, R. J., Rosenfeld, H., Perloff, M. M., Clark, E. L., Schilling, A.: Triazolam in insomniac family practice patients. Clin. Pharmacol. Ther. 18, 315–324 (1975)
Rickels, K., Hesbacher, P. T.: Over-the-counter daytime sedatives: a controlled study. JAMA 223, 29–33 (1973)
Rickels, K., Hesbacher, P. T.: Psychopharmacologic agents: prescription patterns of non-psychiatrists. Psychosomatics 18, 37–40 (1977)
Rickels, K., Hesbacher, P., Fisher, E. L., Norstad, N.: The private practice research group (PPRG): a working model from psychopharmacology for clinical research in family practice. J. Clin. Pharmacology 17, 541–554 (1977)
Rickels, K., Howard, K.: The physician questionnaire: a useful tool in psychiatric drug research. Psychopharmacologia (Berl.) 17, 338–344 (1970)
Rickels, K., Hutchison, J., Morris, R. J., Csanalosi, I., Parsia, K., Pereira-Ogan, J. A.: Molindone and chlordiazepoxide in anxious neurotic outpatients. Curr. Ther. Res. 14, 1–9 (1972)
Rickels, K., Lipman, R. S., Park, L. C., Covi, L., Uhlenhuth, E. H., Mock, J. E.: Drug, doctor warmth, and clinic setting in the symptomatic response to minor tranquilizers. Psychopharmacologia (Berl.) 20, 128–152 (1971)
Rickels, K., Pereira-Ogan, J. A., Case, W. G., Csanalosi, I., Mirman, M. J., Nathanson, J. E., Parish, L. C.: Chlormezanone in anxiety: a drug rediscovered? Am. J. Psychiatry 131, 592–595 (1974)
Rickels, K., Raab, E., DeSilverio, R., Etemad, B.: Drug treatment in depression: antidepressant or tranquilizer? JAMA 201, 675–681 (1967)
Rickels, K., Raab, E., Gordon, P. E., Laquer, K. G., DeSilverio, R. V., Hesbacher, P. T.: Differential effects of chlordiazepoxide and fluphenazine in two anxious patient populations. Psychopharmacologia (Berl.) 12, 181–192 (1968)
Rickels, K., Sablosky, H., Silverman, H., Case, W. G., Rial, W., Mirman, M., Gottlieb, S.: Prazepam in anxiety: a controlled clinical trial. Comp. Psychiatry 18, 239–249 (1977)
Rickels, K., Weise, C. C., Clark, E. L., Jenkins, B. W., Rose, C. K., Rosenfeld, H., Gordon, P. E.: Thiothixene and thioridazine in anxiety. Br. J. Psychiatry 125, 79–87 (1974)
Rickels, K., Weise, C. C., Whalen, E. M., Csanalosi, I., Jenkins, B. W., Stepansky, W.: Haloperidol in anxiety. J. Clin. Pharmacol. 11, 440–449 (1971)
Salzman, C., Kochansky, G. E., Shader, R. I., Porino, L. J., Harmatz, J. S., Swett, C. P.: Chlordiazepoxide-induced hostility in a small group setting. Arch. Gen. Psychiatry 31, 401–405 (1974)
Uhlenhuth, E. H., Duncan, D. B., Park, L. C.: Some nonpharmacologic modifiers of the response to imipramine in depressed psychoneurotic outpatients: a confirmatory study. In: Psychotropic drug response: advances in prediction, P. R. A. May and J. R. Wittenborn, eds., pp. 155–197. Springfield, Ill.: Charles C. Thomas 1969
Uhlenhuth, E. H., Lipman, R. S., Balter, M. B., Stern, M.: Symptom intensity and life stress in the city. Arch. Gen. Psychiatry 31, 759–764 (1974)
Uhlenhuth, E. H., Rickels, K., Fisher, S., Park, L. C., Lipman, R. S., Mock, J.: Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy. Psychopharmacologia (Berl.) 9, 392–418 (1966)
Wheatley, D.: Comparative effects of propranolol and chlordiazepoxide in anxiety states. Br. J. Psychiatry 115, 1411–1412 (1969)
Wheatley, D.: A comparative trial of imipramine and phenobarbital in depressed patients seen in general practice. J. Nerv. Ment. Dis. 148, 542–549 (1969)
Wheatley, D.: Psychopharmacology in Family Practice. London: William Heinemann Medical Books Ltd. 1973
Author information
Authors and Affiliations
Additional information
This paper is an updated version of a presentation given at “Conference on Prescribing and Use of Anti-Anxiety Agents in Outpatients,” held at NIMH, Bethesda, Maryland, U.S.A., May 2 and 3, 1974
Rights and permissions
About this article
Cite this article
Rickels, K. Use of antianxiety agents in anxious outpatients. Psychopharmacology 58, 1–17 (1978). https://doi.org/10.1007/BF00426784
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00426784